Maiden Pharmaceuticals

WHO said it was conducting further investigation with the company and regulatory authorities in India.

As per reports, the Gambian government reported last month that it has been investigating the deaths of small children under the age of 5 years as there was ...

New Delhi: The World Health Organization (WHO) issued a medical product alert on four cough and cold syrups manufactured by Maiden Pharmaceuticals Ltd in ...

The World Health Organization (WHO) on October 5 issued a medical product alert on four contaminated medicines in Gambia. It has identified that the ...

WHO said it was conducting further investigation with the company and regulatory authorities in India. Maiden Pharmaceuticals did not immediately respond to a ...

Alert Summary This WHO Medical Product Alert refers to four substandard products, identified in The Gambia and reported to WHO in September 2022.

To date, these four products have been identified in The Gambia, but may have been distributed, through informal markets, to other countries or regions. To date, the stated manufacturer has not provided guarantees to WHO on the safety and quality of these products. If you have any information concerning the manufacture or supply of these products, please contact WHO via The products’ authenticity and physical condition should be carefully checked. Substandard medical products are products that fail to meet either their quality standards or specifications and are, therefore "out of specification"[1]. The stated manufacturer of these products is Maiden Pharmaceuticals Limited (Haryana, India).

Geneva [Switzerland], October 5 (ANI): The World Health Organization (WHO) on Wednesday issued a medical product alert on four cough and cold syrups made by ...

WHO requested increased surveillance and diligence within the supply chains of countries and regions likely to be affected by these products. Substandard medical products are products that fail to meet either their quality standards or specifications and are, therefore "out of specification," the WHO said. "The four products are Promethazine Oral Solution, Kofexmalin Baby

The WHO also issued a medical product alert asking regulators to remove Maiden Pharma goods from the market. The products may have been distributed ...

WHO said substandard medical products are the products that fail to meet either their quality standards or specifications. All batches of these products should be considered unsafe until they can be analysed by the relevant National Regulatory Authorities. WHO is conducting further investigation with the company and regulatory authorities in India," he said, adding that the loss of young lives due to the products is "beyond heart-breaking for their families". WHO has recommended all countries detect and remove these products from circulation to prevent further harm to patients. The four products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup. [Gambia](/topic/gambia).

Haryana based, Maiden pharmaceuticals company was red flagged by the World Health Organisation due to its potential involvement in the deaths of children in ...

The World Health Organization (WHO) on Wednesday issued an alert alleging a medical product made by an Indian pharma company is linked to the deaths of 66 ...

Quoting WHO chief Tedros Adhanom Ghebreyesus, the body tweeted that it is conducting an investigation with the company and regulatory authorities in India. According to the information on the trade website India Mart, Maiden Pharmaceuticals Limited was established in the year 1990. The world's leading medical body said four contaminated medicines allegedly produced by Maiden Pharmaceuticals Ltd have been potentially linked with acute kidney injuries in children resulting in their deaths.

Following the death of 66 children in the Gambia, the WHO red flagged cough syrups made by Haryana-based Maiden Pharmaceuticals and urged people to not use ...

“We are trying to find out with the buyer and all that what has happened exactly. “We are trying to find out the situation because it cropped up only today morning,” Naresh Kumar Goyal told Reuters. We are not selling anything in India.”

Central Drugs Standard Control Organisation (CDSCO) has taken up an urgent investigation after WHO issued a medical product alert for four India-made cough ...

Substandard medical products are products that fail to meet either their quality standards or specifications and are, therefore "out of specification," the WHO said. Preliminary investigation reveals that Maiden Pharmaceutical Limited, is a Haryana based manufacturer licensed by the State Drug Controller for the products, and also holds manufacturing permission. While all required steps will be taken in the matter, as a robust National Regulatory Authority, WHO has been requested to share at the earliest with CDSCO the report on the establishment of causal relation to death with the medical products in question, photographs of Labels/ products etc.